Regarding the other clinical-pathological features, only vascular invasion and ulceration status showed a trend, not statistically significant, in which the methDNA levels of the SLC22A17 hotspot were increased in advanced CM patients (Supplementary Fig.
← all excerpts
Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.
1
—
—